Furthermore, CTGF, another downstream effector of VEGF whose increase in retinopathy underlies fibrotic processes associated with retinal angiogenesis [28], was also normalized in AAV-hPEDF treated retinas. This evidence concerns the gene CCN2 and retinal disorder.